Primary aldosteronism

• Published in: Gland surgery Vol. 9; no. 1; pp. 14 - 24
• Main Authors: Wrenn, Sean M, Vaidya, Anand, Lubitz, Carrie C
• Format: Journal Article
• Language: English
• Published: China (Republic : 1949- ) AME Publishing Company 01-02-2020
• Subjects: Review; Primary aldosteronism (PA); adrenal gland; Conn’s syndrome; adrenal adenoma; endocrine surgery; endocrine
• ISSN: 2227-684X; 2227-8575
• DOI: 10.21037/gs.2019.10.23

Primary aldosteronism (PA) is a common cause of secondary hypertension caused by excessive and inappropriate secretion of the hormone aldosterone from one or both adrenal glands. The prevalence of PA ranges from 10% in the general hypertensive population to 20% in resistant hypertension, yet only a small fraction of patients is diagnosed. Disease and symptom recognition, screening in indicated populations, multidisciplinary communication, and appropriate imaging and biochemical workup can identify patients who might benefit from effective and targeted treatment modalities. Effective treatments available include both surgical and medical approaches, usually dependent on the subtype of PA present. Our collective understanding of the pathophysiology of PA is expanded by recent developments in molecular biology and genetics, including understanding the specific somatic and germline mutations involved in pathogenesis. We review the pathophysiology, diagnostic workup, and treatment considerations for this disease process.